Burosumab-twza Subcutaneous and Hydromorphone Extended Release
Determining the interaction of Burosumab-twza Subcutaneous and Hydromorphone Extended Release and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: hydromorphone
Brand name: Dilaudid, Exalgo, Hydrostat IR, Dilaudid-HP
Synonyms: Hydromorphone, HYDROmorphone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Hydromorphone Extended-Release Tablets
- Burosumab-twza Subcutaneous-Hydromorphone Hydrochloride
- Burosumab-twza Subcutaneous-Hydromorphone injection
- Burosumab-twza Subcutaneous-Hydromorphone Liquid
- Burosumab-twza Subcutaneous-Hydromorphone rectal
- Burosumab-twza Subcutaneous-Hydromorphone Suppository
- Hydromorphone Extended Release-Buspar
- Hydromorphone Extended Release-Buspar Dividose
- Hydromorphone Extended Release-Buspirone
- Hydromorphone Extended Release-Buspirone Hydrochloride
- Hydromorphone Extended Release-Busulfan
- Hydromorphone Extended Release-Busulfan Concentrate Injection